Authors
Latest:
Woman With Rare Cause of Rectal BleedingA 56-year-old Caucasian woman presented to her primary care physician with a 3-month history of intermittent bright red rectal blood with defecation. At her initial visit, a digital rectal examination, anoscopy, and a pelvic examination with DNA testing for high-risk HPV were performed; all results were negative. She was referred for a colonoscopy, which revealed an abnormal area with a 3 × 4–cm mass in the rectum at a distance of 10 cm from the anal verge.
Latest:
ASTRO 2017: Practice-Changing Abstracts in Prostate, Renal CancersThis video highlights potentially practice-changing studies on genitourinary cancers presented at the 2017 ASTRO Annual Meeting.
Latest:
ASTRO 2017: Immune Markers in Prostate Cancer Predict RT ResponseThis video highlights a new study that found that markers of immune response in prostate cancer may be able to predict patients’ response to radiation therapy, likelihood of recurrence, and survival.
Latest:
Greater Risk of Death in Cancer Patients Who Choose Alternative TherapiesThis video highlights a recent study that looked at the survival impact of cancer patients who chose alternative medicine instead of conventional cancer treatments.
Latest:
Herb-Drug Interactions in Cancer CareIn this article, we describe the mechanisms via which interactions between herbs and prescription drugs may occur, and highlight four popular herbs and a medicinal mushroom commonly used by cancer patients, along with reports of their interactions with standard drugs.
Latest:
Blase Polite on How Disparities Research Must Move Into an Era of ActionIn this interview we discuss health disparities in cancer care, how redesigning cancer clinical trials can address some of these disparities, and goals for the “next generation” of cancer health disparities research.
Latest:
Initiating Exercise Interventions to Promote Wellness in Cancer Patients and SurvivorsThis article includes a succinct review of current research into exercise in the cancer setting and a discussion of the American College of Sports Medicine exercise recommendations for cancer survivors. Common acute, long-term, and late effects of cancer and its treatment are also described in the context of ways in which these side effects impact the ability to exercise.
Latest:
Initiating Exercise Interventions to Promote Wellness in Cancer Patients and SurvivorsThis article includes a succinct review of current research into exercise in the cancer setting and a discussion of the American College of Sports Medicine exercise recommendations for cancer survivors. Common acute, long-term, and late effects of cancer and its treatment are also described in the context of ways in which these side effects impact the ability to exercise.
Latest:
Multidisciplinary Approaches to Chest Wall Recurrences of Breast CancerA chest wall recurrence of breast cancer following mastectomy is a complex clinical problem that can push centers to the limits of their resources.
Latest:
Multidisciplinary Approaches to Chest Wall Recurrences of Breast CancerA chest wall recurrence of breast cancer following mastectomy is a complex clinical problem that can push centers to the limits of their resources.
Latest:
Pneumonitis From Anti–PD-1/ PD-L1 TherapyWhile the incidence of irAEs is relatively low, the absolute number of patients receiving immune checkpoint inhibitors is steadily increasing. Thus, it is likely that, with time, larger numbers of patients will develop irAEs, including pneumonitis.
Latest:
Pneumonitis From Anti–PD-1/ PD-L1 TherapyWhile the incidence of irAEs is relatively low, the absolute number of patients receiving immune checkpoint inhibitors is steadily increasing. Thus, it is likely that, with time, larger numbers of patients will develop irAEs, including pneumonitis.
Latest:
Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'We will provide a brief orientation on the research that has defined our understanding of breast cancer disparities to date, as well as promising emerging data sources and methods that may take us further in the quest to close the racial survival gap and provide better cancer care to vulnerable populations.
Latest:
Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'We will provide a brief orientation on the research that has defined our understanding of breast cancer disparities to date, as well as promising emerging data sources and methods that may take us further in the quest to close the racial survival gap and provide better cancer care to vulnerable populations.
Latest:
Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'We will provide a brief orientation on the research that has defined our understanding of breast cancer disparities to date, as well as promising emerging data sources and methods that may take us further in the quest to close the racial survival gap and provide better cancer care to vulnerable populations.
Latest:
Determining Suitable Radioligand Therapy Use in Neuroendocrine TumorsOncologists discuss data from the NETTER-1 and NETTER-2 trials and the extent to which they support the applicability of 177Lu-dotatate in NETs.
Latest:
Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and ManagementIn this review, we focus on the treatment of well-differentiated early and metastatic PNETs, emphasizing current controversies, recent advances in therapy, and the multidisciplinary approach required for optimal treatment.
Latest:
Fumiko Chino, MD, on Next Steps in Evaluating Medicare’s Impact on Cancer Mortality RatesThe expert explained how states that expanded Medicaid coverage saw a steeper decline in cancer mortality rates, and next steps for further evaluation.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
POINT: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate CancerSerial PSA testing with early salvage radiotherapy is a viable option in most high-risk men.
Latest:
COUNTERPOINT: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate CancerThe data for adjuvant radiotherapy remain strong.
Latest:
Which Drug Is Contraindicated in RVD-Treated Multiple Myeloma Patients?Do you know when to switch treatment combinations or stop certain treatments altogether in the management of patients with multiple myeloma? Take part in a series of case scenarios and see if you can pick the correct course of action for each in our latest quiz.
Latest:
Pneumonitis From Anti–PD-1/ PD-L1 TherapyWhile the incidence of irAEs is relatively low, the absolute number of patients receiving immune checkpoint inhibitors is steadily increasing. Thus, it is likely that, with time, larger numbers of patients will develop irAEs, including pneumonitis.
Latest:
Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and ManagementIn this review, we focus on the treatment of well-differentiated early and metastatic PNETs, emphasizing current controversies, recent advances in therapy, and the multidisciplinary approach required for optimal treatment.
Latest:
Early Palliative Care Improves QOL for Lung and GI Cancer PatientsThe early integration of oncology and palliative care enhanced coping strategies and improved QOL for patients newly diagnosed with incurable lung or GI cancer.
Latest:
Radiation Oncologist Speaks to AI Potential in the Cancer SpaceRichard Bakst, MD, speaks to the potential use of artificial intelligence in the radiation oncology space, and how he hopes to see it evolve.
